Search
for
Sort by
Research 751–780 of 1000+
- Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data
- Janus kinase inhibitors for alopecia areata: A narrative review
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Alopecia areata – Aktuelles Verständnis und Management
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- The COVID-19 pandemic and its skin effects
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment
- Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
- Moisturizers, Lubricants, and Vulvar Hygiene Products: Issues, Answers, and Clinical Implications
- Experts’ view on the management of scalp seborrheic dermatitis in Italy
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Universal Dermatology: Bridging Gaps in Skin Health
- A Comprehensive Review of GWASs of Human Hair Traits
- Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color
- Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- Menopause and hair loss in women: Exploring the hormonal transition
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders